文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The Antigenicity of the Tumor Cell - Context Matters.

作者信息

Kristensen Vessela N

机构信息

From the Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, and the Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo - both in Norway.

出版信息

N Engl J Med. 2017 Feb 2;376(5):491-493. doi: 10.1056/NEJMcibr1613793.

DOI:10.1056/NEJMcibr1613793
PMID:28146670
Abstract
摘要

相似文献

[1]
The Antigenicity of the Tumor Cell - Context Matters.

N Engl J Med. 2017-2-2

[2]
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.

Science. 2016-5-19

[3]
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.

Eur J Immunol. 2010-6

[4]
Neoantigen landscape dynamics during human melanoma-T cell interactions.

Nature. 2016-6-27

[5]
IMMUNOTHERAPY. Outsourcing the immune response to cancer.

Science. 2016-6-10

[6]
Cancer immunotherapy using tumor antigen-reactive T cells.

Immunotherapy. 2018-3

[7]
MAGE-C2-Specific TCRs Combined with Epigenetic Drug-Enhanced Antigenicity Yield Robust and Tumor-Selective T Cell Responses.

J Immunol. 2016-9-15

[8]
Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.

Semin Oncol. 2015-8

[9]
T cell-defined melanoma antigens: toward a tumour-specific immunotherapy of the disease.

Melanoma Res. 1993-12

[10]
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.

Cancer Immunol Res. 2016-8

引用本文的文献

[1]
Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification.

Vaccines (Basel). 2025-8-15

[2]
Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and Prospects.

Cancers (Basel). 2025-6-12

[3]
Characterization of T-Cell Receptor Profiles Predicts Survival Situation in Patients with Hepatocellular Carcinoma.

Technol Cancer Res Treat. 2025

[4]
Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening.

Front Immunol. 2024

[5]
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer.

Cancer Immunol Immunother. 2024-5-14

[6]
An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma.

Front Immunol. 2023

[7]
Neoantigens: promising targets for cancer therapy.

Signal Transduct Target Ther. 2023-1-6

[8]
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages.

BMC Cancer. 2021-9-8

[9]
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence.

Signal Transduct Target Ther. 2021-8-20

[10]
The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.

Aging (Albany NY). 2020-12-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索